期刊文献+

新型格尔德霉素葡萄糖苷的制备及其诱导人乳腺癌MCF-7细胞凋亡的作用 被引量:1

Preparation of a novel geldanamycin glucoside and its induction effects on the apoptosis of human breast cancer MCF-7 cells
下载PDF
导出
摘要 目的:对非苯醌格尔德霉素进行酶法糖基化修饰,并探讨其糖基化产物对乳腺癌细胞增殖、凋亡的影响。方法:利用体外酶法糖基化反应制备新型非苯醌格尔德霉素糖基化产物,并经质谱和核磁共振解析鉴定其结构。采用孔雀绿-钼酸铵显色反应、MTT法、PI单染/流式细胞术检测化合物的体外抗肿瘤活性。免疫印迹法检测化合物对Akt、Bcl-2及热休克蛋白90(Hsp90)表达的影响。结果:新型非苯醌格尔德霉素糖基化产物鉴别为17-demethoxy-reblastatin-18-O-β-D-glucopyranoside(1)。化合物1具有显著抑制Hsp90 ATPase活性,其IC50值为8.98μmol/L。化合物1对人乳腺癌MCF-7细胞表现出一定的抑制增殖、诱导凋亡的作用,且呈现浓度依赖性。免疫印迹法结果显示,随着化合物1浓度的增加,诱导Akt和Bcl-2蛋白的降解越明显,而对Hsp90蛋白的表达没有影响。结论:新型Hsp90抑制剂化合物1具有抑制MCF-7细胞增殖、诱导凋亡能力,其机制可能是通过抑制Hsp90 ATPase活性以及诱导降解Hsp90顾客蛋白Akt和Bcl-2有关。 Objective:To explore the effects of the enzymatic glycosylation product modified by enzymatically non-benzoquinone geldanamycin(GA)on the proliferation and apoptosis of breast cancer cells.Methods:A new non-benzoquinone GA glucoside was prepared using enzymatic glycosylation in vitro.The product was characterized by ESI-MS and nuclear magnetic resonance(NMR)analysis.The anti-cancer activities of the compound were evaluated using malachite green-molybda colour reaction,MTT assay and flow cytometry with PI staining in vitro.The effects of the compound on expression levels of Akt,Bcl-2 and heat shock protein 90(Hsp90)were detected using Western blot.Results:The structure of novel non-benzoquinone GA glucoside was characterized as 17-demethoxy-reblastatin-18-O-β-D-glucopyranoside(1).Compound 1 could significantly inhibit the activity of Hsp90 ATPase,the IC50 value of which was 8.98μmol/L.Compound 1 could inhibit the proliferation,and induce apoptosis in MCF-7 cells of human breast cancer in a concentration-dependent manner.The results of Western blot showed that,with the increasing of compound 1 concentration,the induced degradation of Akt and bcl-2 protein was more obvious,while the expression of Hsp90 protein was not affected.Conclusions:The new Hsp90 inhibitor,compound 1,can inhibit the proliferation,and induce apoptosis of MCF-7 cells,the mechanism of which may be by inhibiting the activity of Hsp90 ATPase,and inducing the degradation of Hsp90 client protein Akt and Bcl-2.
作者 李红梅 李静 霍强 金勇 吴成柱 LI Hong-mei;LI Jing;HUO Qiang;JIN Yong;WU Cheng-zhu(School of Pharmacy,Bengbu Medical College,Bengbu Anhui 233030;School of Pharmacy,Yanbian University,Yanji Jilin 133002,China)
出处 《蚌埠医学院学报》 CAS 2020年第3期300-305,共6页 Journal of Bengbu Medical College
基金 国家自然科学基金项目(81302671) 安徽省高校自然科学研究重点项目(KJ2016A465)。
关键词 乳腺肿瘤 格尔德霉素 热休克蛋白90 糖基化 凋亡 breast neoplasms geldanamycin heat shock protein 90 glycosylation apoptosis
  • 相关文献

参考文献4

二级参考文献42

  • 1Bryan BB, Schnitt S J, Collins LC. Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer[J]. Mod Pathol, 2006, 19(5): 617-21.
  • 2Whitesell L, Lindquist SL. Hsp90 and the charperoning of cancer [J]. Nat Rev Cancer, 2005, 5: 761-72.
  • 3Sankhala KK, Mira MM, Mira AC. Heat shock proteins: a potential anticancer target[J]. Curr Drug Targets, 2011, 12(14): 2001-8.
  • 4Seijas JA, Vizouez-Tatomp MP, Martinez MM, et al. Synthesis of anacardic acids by nucleophilis substitution on 2-aryloxazolines[J]. Tetrahedron Lett, 2004, 45(9): 1937-9.
  • 5Pea AI, Schmidt JM, Setzer WN, et al. Cytotoxic activity of Ozorpa insignis from Zimbabwe[J]. Fitoterapia, 2003, 74(7-8): 732-35.
  • 6Kubo I, Ochi M, Vieira PC, et al. Antitumor agents from the Cashew (Anaeardium occidentale) apple juice [J]. J Agric Food Chem, 1993, 41: 1012-015.
  • 7Schultz DJ, Wickramasinghe NS, Ivanova MM, et al. Anacardic acid inhibits estrogen receptor alpha-DNA binding and reduces target gene transcription and breast cancer cell proliferation[J]. Mol Cancer Ther, 2010, 9(3): 594-605.
  • 8Wu CZ, Moon AN, Choi O, et al. 6-Alkylsalicylic acid analogues inhibit in vitro ATPase activity of heat shock protein 90 [J]. Arch Pharm Res, 2010, 33(12): 1997-2001.
  • 9Kamal A, Thao L, Sensintaffar J, et al. A big-affinity conformation of Hsp90 confers tumor selectivity on Hsp90 inhibitors[J]. Nature, 2003, 425(6956): 407-10.
  • 10Mehta PP, Whalen P, Baxi SM, et al. Effective targeting of triple-negative breast cancer cells by PF-4942847, a novel oral inhibitor of Hsp90[J]. Clin Cancer Res, 2011, 17(16): 5432-42.

共引文献34

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部